The AI radiology company Synapsica is expanding its PACS offering to other Indian cities
Synapsica, an AI radiology reporting company, has partnered with GenWorks Health, a healthcare solutions provider supported by Wipro GE Healthcare, to roll out its Image Archiving and Communication System (PACS) in more cities across India.
Radiolens’ radiology workflow solution automatically detects poor quality scans and prepares preliminary reports for the most common modalities. It also offers AI-driven quantitative and qualitative actionable insights.
This partnership provides access to the radiology product in over 300 Tier 2 and Tier 3 cities and towns such as Maharashtra, Andhra Pradesh, West Bengal and Chennai.
Synapsica is helping to address the shortage of radiologists in India, who currently number around 10,000 per billion people. This, coupled with the increasing demand for radiological reporting, puts a strain on radiologists’ time spent on screening reports, sometimes resulting in “inadequate” and “incorrect” reports.
Thus, Radiolens supports radiologists by automating several tasks in their workflow and at the same time offers “greater insights for a more objective result”.
“We are confident that GenWorks, with its deep network, will bring our solution to healthcare providers in Tier 2 and Tier 3 cities and towns across the country, enabling us to help these hospitals and diagnostic laboratories produce high quality Generate radiology reports, “said Synapsica co-founder and CEO Meenakshi Singh said.
South Korean AI medical imaging startup unveils CT noise reduction solution
ClariPi, an AI medical imaging startup based in South Korea, has launched an AI-powered low-dose CT noise reduction solution along with its other new AI imaging products.
Trained with over a million images, ClariCT.AI eliminates image noise with a “significantly reduced” radiation dose.
The system, which has been released in both the US and Europe, will soon be available on the Nuance AI marketplace.
In the meantime, ClariPi has introduced a software-based iodine contrast enhancement solution called ClariACE, which minimizes side effects in contrast-enhanced CT scans; ClariPulmo, a fully automated 3D reporting solution for pneumonia and emphysema caused by COVID-19; and ClariOsteo, an AI precision bone restoration solution for both low and ultra-low dose CT images.
AICS presents its latest intelligent medical solutions
Taiwan-based ASUS Intelligent Cloud Services (AICS) announced some of its latest intelligent medical solutions.
The xHIS platform is an AI cloud-based hospital information system that enables digitization through the integration of AI services and the optimization of the quality of the writing of medical records, the procedure coding system, the issuing and application process of doctor’s orders and the computer-aided entry of doctor’s orders . It was introduced at Taipei Tzu Chi Hospital, which claims that the system, when used in conjunction with their clinical decision support system, improves multidisciplinary collaboration and communication between doctors and patients.
The AICS Lumos EMR search platform analyzes medical records and exam reports. It also provides real-world data such as variation trends and disease factors that have supported research and clinical treatment at Chung Shan Medical University Hospital (CSMUH).
Another AICS product is the Drug Safety Service, which was jointly developed with Cheng Hsin General Hospital. The AI-assisted drug safety system reviews a patient’s family and personal health information, then recommends drugs and tests. It also indicates when an abnormal dose of medication is being prescribed, helping to reduce human error, disputes, and medical waste.
Finally, AICS also worked with the CSMUH to develop a platform for personal health management. The CSMUH eServices app, supported by the AICS Personal Healthcare App, offers a smart mobile clinic, chronic disease management and personalized long-term care. It has a structured medical database that combines AI, mobile and telematics technologies.